Login
Lost password ?
Create account
Main menu
Home
Practical Information
Registration
List of Participants
Additional information
Program
Abstract submission
Sponsors
HELP
@ Contact
Program
Friday, September 16, 2022
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
›8:30 (30min)
Registration and Celcome
8:30 - 9:00 (30min)
Registration and Celcome
›9:00 (10min)
Few words of introduction
Mélanie Prague & Jeremie Guedj
9:00 - 9:10 (10min)
Few words of introduction
Mélanie Prague & Jeremie Guedj
›9:10 (30min)
Modelling B cell response to vaccine. Exemple of Ad26/MVA against Ebola virus disease
Rodolphe Thiébaut, Université Bordeaux
9:10 - 9:40 (30min)
Modelling B cell response to vaccine. Exemple of Ad26/MVA against Ebola virus disease
Rodolphe Thiébaut, Université Bordeaux
›9:40 (20min)
A multi-strain model of immunization against IAV viruses after infection or vaccination
Nicolas Ratto, Nova Discovery
9:40 - 10:00 (20min)
A multi-strain model of immunization against IAV viruses after infection or vaccination
Nicolas Ratto, Nova Discovery
›10:00 (20min)
Modeling viral and humoral dynamics after vaccination against SARS-CoV-2 in NHPs
Marie Alexandre, INRIA
10:00 - 10:20 (20min)
Modeling viral and humoral dynamics after vaccination against SARS-CoV-2 in NHPs
Marie Alexandre, INRIA
›10:20 (40min)
Coffee break
10:20 - 11:00 (40min)
Coffee break
›11:00 (30min)
Modeling SARS-CoV-2 Drug Resistance and Paxlovid Viral Rebound
Alan Perelson, Los Alamos National Laboratory
11:00 - 11:30 (30min)
Modeling SARS-CoV-2 Drug Resistance and Paxlovid Viral Rebound
Alan Perelson, Los Alamos National Laboratory
›11:30 (20min)
Modeling within-host and aerosol dynamics of SARS-CoV-2
Stanca Ciupe, Virginia Tech
11:30 - 11:50 (20min)
Modeling within-host and aerosol dynamics of SARS-CoV-2
Stanca Ciupe, Virginia Tech
›11:50 (20min)
Using NHPs to characterize the impact of variants of concern on viral dynamics
Aurélien Marc, INSERM
11:50 - 12:10 (20min)
Using NHPs to characterize the impact of variants of concern on viral dynamics
Aurélien Marc, INSERM
›12:10 (20min)
Comparative assessment of SARS-CoV-2 viral dynamic models to inform pharmacodynamic model development in early treatment trials
Joseph Standing, University College London
12:10 - 12:30 (20min)
Comparative assessment of SARS-CoV-2 viral dynamic models to inform pharmacodynamic model development in early treatment trials
Joseph Standing, University College London
›12:30 (1h)
Lunch
12:30 - 13:30 (1h)
Lunch
›13:30 (30min)
What can we expect to learn from multiscale models?
Lulla Opatowski, Institut Pasteur
13:30 - 14:00 (30min)
What can we expect to learn from multiscale models?
Lulla Opatowski, Institut Pasteur
›14:00 (20min)
Impact of antiviral treatment on household transmission
Hind Zaaraoui, INSERM
14:00 - 14:20 (20min)
Impact of antiviral treatment on household transmission
Hind Zaaraoui, INSERM
›14:20 (20min)
Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventions
Alexander Kulesza, Nova Discovery
14:20 - 14:40 (20min)
Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventions
Alexander Kulesza, Nova Discovery
›14:40 (20min)
Light Coffee break
14:40 - 15:00 (20min)
Light Coffee break
›15:00 (30min)
A cohort study to describe and model HPV kinetics
Baptiste Elie, CNRS
15:00 - 15:30 (30min)
A cohort study to describe and model HPV kinetics
Baptiste Elie, CNRS
›15:30 (20min)
Mechanistic Immune-Viral Dynamics Modeling Platform for HIV Cure Drug Development
Laura Liao, Merck
15:30 - 15:50 (20min)
Mechanistic Immune-Viral Dynamics Modeling Platform for HIV Cure Drug Development
Laura Liao, Merck
›15:50 (20min)
Dynamics of HBV markers during long-term treatment with lamivudine and peg-IFN
Selma El Messaoudi, INSERM
15:50 - 16:10 (20min)
Dynamics of HBV markers during long-term treatment with lamivudine and peg-IFN
Selma El Messaoudi, INSERM
›16:10 (15min)
Break
16:10 - 16:25 (15min)
Break
›16:25 (20min)
Withdraw
Withdraw
16:25 - 16:45 (20min)
Withdraw
Withdraw
›16:45 (20min)
Within-Host Stochastic Emergence Dynamics of Immune-Escape Mutants
Samuel Alizon, CNRS
16:45 - 17:05 (20min)
Within-Host Stochastic Emergence Dynamics of Immune-Escape Mutants
Samuel Alizon, CNRS
›17:05 (20min)
Modeling synergistic dynamics in phage therapy
Joshua Weitz, Georgia Tech
17:05 - 17:25 (20min)
Modeling synergistic dynamics in phage therapy
Joshua Weitz, Georgia Tech
›17:25 (05min)
Wrap-up
Mélanie Prague & Jérémie Guedj
17:25 - 17:30 (05min)
Wrap-up
Mélanie Prague & Jérémie Guedj
Session
Speech
Logistics
Break
Tour
Online user:
1
RSS Feed
|
Privacy
Loading...
Loading... 
